CLINICAL_TRIALS
trial_result
· 2026-03-25
Clinical Trial Update: TP-3654 Food Effect Study [Phase 1]
Summary
Phase 1 food-effect study of TP-3654 in myelofibrosis has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Sumitomo Pharma America, Inc. | Conditions: Myelofibroses | Phase 1 | Status: COMPLETED